St. Joseph 81 mg Chewable Aspirin Interactions
There are 347 drugs known to interact with St. Joseph 81 mg Chewable Aspirin (aspirin), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 54 are major, 247 are moderate, and 46 are minor.
- View all 347 medications that may interact with St. Joseph 81 mg Chewable Aspirin
- View St. Joseph 81 mg Chewable Aspirin alcohol/food interactions (2)
- View St. Joseph 81 mg Chewable Aspirin disease interactions (9)
Most frequently checked interactions
View interaction reports for St. Joseph 81 mg Chewable Aspirin (aspirin) and the medicines listed below.
- albuterol
- albuterol
- amlodipine
- amlodipine
- atorvastatin
- atorvastatin
- carvedilol
- carvedilol
- furosemide
- furosemide
- gabapentin
- gabapentin
- lisinopril
- lisinopril
- losartan
- losartan
- metformin
- metformin
- metoprolol
- metoprolol
- omeprazole
- omeprazole
- simvastatin
- simvastatin
- tramadol
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
St. Joseph 81 mg Chewable Aspirin alcohol/food interactions
There are 2 alcohol/food interactions with St. Joseph 81 mg Chewable Aspirin (aspirin).
St. Joseph 81 mg Chewable Aspirin disease interactions
There are 9 disease interactions with St. Joseph 81 mg Chewable Aspirin (aspirin) which include:
- coagulation
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
More about St. Joseph 81 mg Chewable Aspirin (aspirin)
- Compare alternatives
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet aggregation inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.